Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Topically applied clostridium botulinum toxin compositions and treatment methods

a technology of clostridium botulinum toxin and compositions, applied in the field of medicine, can solve the problems of destroying clothing, affecting the health of patients, and affecting the effect of treatment, and achieve the effect of convenient application directly by patients

Inactive Publication Date: 2003-06-19
COLEMAN WILLIAM P III
View PDF2 Cites 133 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0017] Another goal of the invention is to provide a method and compositions for the treatment of hyperhidrosis that are painless and easy to apply directly by a patient.

Problems solved by technology

While the potency of these toxins differ somewhat (and their physiological modes of action vary), they all result in chemodenervation.
Death often results from a gradual paralysis of the muscles required for respiration.
This disorder, which appears to be genetically based, is a cause of great distress for sufferers.
It can also be expensive.
Aside from the disruption of normal social activities, excessive sweating frequently discolors and thereby ruins clothing.
All of these therapies have significant drawbacks and are often unsuccessful.
First, introducing BOTOX through intradermal injections is painful and often involves numerous percutaneous sticks in order to provide relief for the affected area. Moreover, because relief is only temporary, having a medical practioner administer each follow-up injection can be time-consuming, costly, and inconvenient.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0020] The present invention features methods for the treatment of maladies of the smooth muscle and sweat glands, such as hyperhidrosis, bromhidrosis, chromhidrosis, and nevus sudoriferous. The invention also includes compositions of topically formulated botulinum toxin to be used according to the methods described below for glandular disorders such as excessive oil production.

[0021] Three commercial forms of botulinum toxin are presently available, including the A toxin ("BOTOX.TM.," Allergan, Inc.; and "DYSPORT.TM.," Ipsen Limited) and the B toxin ("MYOBLOC.TM.," Elan Pharmaceuticals, Inc.). To the best of the applicant's knowledge, the toxins above have been used exclusively in an injectable form. Two reasons for this probably relate to the perception that botulinum toxin must enter the muscles to be effective and to the difficulty of passing large molecules across the skin.

[0022] Drug penetration is hampered by the relatively low permeability of skin because the barrier propert...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
mechanicalaaaaaaaaaa
chemicalaaaaaaaaaa
compositionsaaaaaaaaaa
Login to View More

Abstract

Hyperactive glandular conditions are treated using topically formulated botulinum toxin compositions. In the preferred embodiment of the invention, topical botulinum preparations are applied directly to the skin by a patient as needed to suppress his or her hyperhidrosis, bromhidrosis, chromhidrosis, nevus sudoriferous, acne, seborrhiec dermatitis or other glandular condition. In other embodiments, topical botulinum toxins are applied with the aid of mechanical, electrical, and / or chemical transdermal delivery enhancers.

Description

[0001] This application is based on U.S. Provisional Patent Application Serial No. 60 / 343,389, filed on Dec. 18, 2001, and entitled "Method and Compositions for Treatment of Hyperhidrosis Using Clostridium Botulinum Toxin." The contents of the Provisional Patent Application are incorporated herein by reference.[0002] 1. Field of the Invention[0003] This invention relates generally to the field of medicine. In particular, it relates to methods and compositions that are especially suitable for the treatment of hyperhidrosis, and other conditions of the glands, skin, or smooth and skeletal muscle, and involve the topical application of one or more microbial neurotoxins.[0004] 2. Description of the Related Art[0005] Traditionally, bacterial toxins, such as those produced by the genus Clostridia, were best known for their wide-ranging pathogenic effects, including food poisoning, tetanus, and botulism. Virulent botulinum strains are divided into seven groups, with each group producing an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K38/48A61K47/06A61K47/10A61K47/14A61K47/38
CPCA61K9/0014A61K38/4893A61K47/38A61K47/10A61K47/14A61K47/06Y02A50/30
Inventor COLEMAN, WILLIAM P. III
Owner COLEMAN WILLIAM P III
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products